You will move to an external webpage. Are you sure?

Nobelpharma

News & Press Release

  • 2025-03-28 Product Information

Marketing Approval Granted for Melatobel Tablet 1 mg/2 mg for Pediatric, A Melatonin Receptor Agonist that Improves the Sleep Onset

  1. 前の記事へ
  2. 一覧へ戻る（英語）
PAGE TOP
  1. HOME
  2. News & Press Release
  3. Marketing Approval Granted for Melatobel Tablet 1 mg/2 mg for Pediatric, A Melatonin Receptor Agonist that Improves the Sleep Onset